Press "Enter" to skip to content

New patent expiration for Horizon Theraps drug RAVICTI

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Horizon Theraps drug RAVICTI

Annual Drug Patent Expirations for RAVICTI
Annual Drug Patent Expirations for RAVICTI

Ravicti is a drug marketed by Horizon Theraps Inc and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug and one Paragraph IV challenge.

Drug patent litigation for RAVICTI.

This drug has seventy-seven patent family members in twenty-nine countries.

The generic ingredient in RAVICTI is glycerol phenylbutyrate. One supplier is listed for this compound. Additional details are available on the glycerol phenylbutyrate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent expiration for Horizon Theraps drug RAVICTI
Do NOT follow this link or you will be banned from the site!